CDCP1 and glioblastoma: In conclusion, we analyzed and verified that CDCP1 promotes the transformation of PN-GBM to MES-GBM by promoting the EMT process and immune infiltration, and we identified CD44 and ITGAM, which may interact with CDCP1, through a series of screening methods.